SEARCH RESULT

Total Matching Records found : 4530

SC ‘very serious’ tag on Ranbaxy charges-R Balaji

-The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material". The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening...

More »

Hospitals, chemists to wait for regulatory word on Ranbaxy

-PTI Drug regulator DGCI is conducting a "focussed scrutiny" of medicines sold by Ranbaxy and some other drug makers, but says it remains confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products. While the company continues to assert that its drugs meet all regulatory standards, a few hospitals and pharmacies have adopted a cautious stand on use of its products. However, a majority...

More »

Global leaders sign comprehensive charter to tackle stunting in children -Kounteya Sinha

-The Times of India LONDON: The fight against stunting - the world's most urgent nutritional challenge - got a big boost through a global agreement signed by world leaders in London on Saturday. The Global Nutrition for Growth Compact signed by countries and global leaders committed to reduce the number of children under five who are stunted by an additional 20 million in developing countries like India by 2020. At present stunting...

More »

Training 500 mn people by 2022 unrealistic: Govt think-tank IAMR -Vikas Dhoot

-The Economic Times NEW DELHI: The Manmohan Singh government's target of skilling 500 million people by 2022 is grossly inflated and is based on a speech by late management guru CK Prahalad instead of any demographic analysis. The country would actually need only about half that number of trained manpower by then, the government's own think-tank, the Institute of Applied Manpower Research (IAMR), has said in a research paper. The IAMR, housed under...

More »

PIL in apex court against Ranbaxy

-The Telegraph The Supreme Court today refrained from passing any order on a plea for early listing of a PIL that had sought closure of pharmaceutical giant Ranbaxy, recently penalised by US authorities for allegedly supplying adulterated and substandard drugs. The public interest petition sought registration of criminal cases under the penal code and also the Drugs and Cosmetics Act, 1947, against company officials for allegedly cheating millions of patients in the...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close